QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
Trial ID or NCT#
Status
Purpose
The purpose of this study is show that intensity-modulated radiotherapy (IMRT), as compared with conventional radiotherapy, improves the precision of tumor targeting and reduces the acute and late effects of radiation toxicity when used to treat anal cancer. Results from this work will provide a basis for incorporating the use of IMRT to treat anal cancer in future treatment protocols.
Official Title
Quality of Life and Functional Outcomes After Combined Modality Therapy for Anal Cancer: A Comparison of Conventional Versus Intensity-Modulated Radiation Therapy (ANAL0002)
Eligibility Criteria
- Histologically confirmed diagnosis of squamous cell carcinoma of the anus. Must be able to provide informed consent.
- History of new malignancy since the time of treatment for anal cancer. Non-English speaking.
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Moe Jalali
6507244023
View on ClinicalTrials.gov